Literature DB >> 24200218

Prompt efficacy of very low-dose rituximab on monoclonal B lymphocytosis in a rheumatoid arthritis patient.

Vincenzo Bruzzese1, Cinzia Marrese, Cesare Hassan, Alessandro Andriani, Angelo Zullo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24200218     DOI： 10.1111/1756-185X.12200

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN： 1756-1841            Impact factor:   2.454


× No keyword cloud information.
  2 in total

Review 1.  bDMARD Dose Reduction in Rheumatoid Arthritis: A Narrative Review with Systematic Literature Search.

Authors:  Lise M Verhoef; Lieke Tweehuysen; Marlies E Hulscher; Bruno Fautrel; Alfons A den Broeder
Journal:  Rheumatol Ther       Date:  2017-03-02

2.  Ultra-low dose of rituximab in rheumatoid arthritis: study protocol for a randomised controlled trial.

Authors:  Alfons A den Broeder; Lise M Verhoef; Jaap Fransen; Rogier Thurlings; Bart J F van den Bemt; Steven Teerenstra; Nadine Boers; Nathan den Broeder; Frank H J van den Hoogen
Journal:  Trials       Date:  2017-08-30       Impact factor: 2.279
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.